2023-12-14 07:30:23
At the end of last week, the National Medicines Safety Agency (ANSM) invited doctors to no longer “initiate treatment with Ozempic, Victoza or Trulicity”, drugs which have a “therapeutic interest” in the management of insufficiently controlled type 2 diabetes. Behind the terms used, the public establishment encouraged specialists to no longer prescribe these molecules to new diabetic patients, due to lack of sufficient reserves. Every day or almost, a new name extends the list of missing health products. . Antibiotics, antidiuretics, antiarrhythmics, analgesics: all therapeutic classes are affected. The scourge is not recent. Tensions on supplies have
1702560365
#Unacceptable #proportions #shortage #medicines #worsening #France
